The Company also announced that Dr. Nasser Khan resigned from his role as Chief Operating Officer, effective November 3, 2025. Dr. Khan will continue to serve as an executive advisor through December 31, 2025. The Company has initiated a search for his replacement, and in the interim, Dr. Khan’s responsibilities are being assumed by other members of executive management.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare lowers FY25 adjusted EPS $2.35-$2.45 from $2.45-$2.65
- Acadia Healthcare taking ‘decisive action to drive improved performance’
- Acadia Healthcare sees FY25 EPS $2.35-$2.45, consensus $2.47
- Acadia Healthcare reports Q3 adjusted EPS 72c, consensus 66c
- ACHC Earnings Report this Week: Is It a Buy, Ahead of Earnings?